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httpcense.Abstract Background: Tuberculosis despite being treatable & preventable disease, it continues to
be a major health challenge in many parts of the world. The emergence of drug-resistant tubercu-
losis has made the current epidemic worse.
Methods: This retrospective study included 200 MDR-TB patients admitted to Abbassia Chest
Hospital in the period between July 2006 and June 2010. Their ﬁles had been analyzed including
medical history, chest examination and investigations. Drug regimens of resistance used for treat-
ment and the fate of treatment were reported.
Results: Patients were 148 males (74%) and 52 females (26%). Their ages ranged from 15 to
76 years (37.83 ± 12.78 years). 81.5% of them lived in rural areas, 2.5% were tobacco smokers
and were diabetics. Defaulters were 44.5%, treatment failure patients were 44%, relapse patients
were 4%, and new cases constituted 7.5% of the studied patients. Acquired resistance was 92.5%
and primary resistance was 7.5%. The duration for sputum conversion ranged from 2 to 9 months
(4.19 ± 1.28 months). The fate of MDR-TB treatment was favorable outcome in 132 cases (66%)esistant tuberculosis; WHO,
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338 I.I. Elmahallawy et al.and unfavorable in 68 cases (34%) [28 patients were defaulters (14%), 21 patients died (10.5%) and
19 patients had treatment failure (9.5%)]. The prevalence of defaulter patients was signiﬁcantly
higher among unfavorable outcome patients while the prevalence of treatment failure patients
was signiﬁcantly higher among favorable outcome.
Conclusion: Successful treatment could be achieved in 66% of MDR-TB patients treated in
Abbassia Chest Hospital between July 2006 and June 2010.
ª 2012 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.Introduction
Tuberculosis is a global problem worldwide. About one third
of the world’s population are infected with mycobacterium
tuberculosis or have active tuberculosis; making it the second
leading infectious cause of death globally. In 2006; 9.2 million
incident cases were reported and 1.2 million people died as a
result of tuberculosis [1]. According to the WHO tuberculosis
proﬁle for Egypt in 2004; the prevalence rate of new cases of
MDR-TB was 2.2%, while that of the previously treated tuber-
culous cases that were discovered to be multi drug-resistant
was 38% [2].
Methods
This retrospective study was conducted on 200 MDR-TB pa-
tients admitted to Abbassia Chest Hospital in the period be-
tween July 2006 and June 2010. Their ﬁles had been analyzed
and the following data was collected: (1): full medical history;
including age, sex, occupation, residence, special habits, history
of previous anti-TB treatment, type of resistance either second-
ary (185 cases; 92.5%) or primary resistance (15 cases; 7.5%),
history of previous anti-TB treatment regarding the place of
treatment [hospital (74 cases; 37%), home (111 cases (55.5%)
and 15 cases (7.5%) did not receive any anti-TB treatment], pa-
tients compliance [97 cases (48.5%) with irregular drug intake
and 88 cases (44%) with regular drug intake], regimen of
anti-TB treatment received [category 1: 2HRZE(S)/4HR, cate-
gory 2: 2HRZES/1HRZE/5HR or both (failed category 1 and
received category 2)] and the type of patients [treatment failure
(88 cases; 44%), defaulters (89 cases; 44.5%), new cases (15
cases; 7.5%) or relapse (8 cases; 4%), (2) thorough general
and local chest examination, (3) plain chest X-ray postero-ante-
rior and lateral views, (4) routine laboratory investigations, (5)
examination of sputum smears by ZN staining for three succes-
sive days, (6) sputum culture on Lowenstein-Jensen media, (7)
drug regimens of resistance used according to drug sensitivity
tests and past history of anti-TB drugs. The most frequently
used regimen consisted of:
 3 months: Kanamycin daily + Oﬂoxacin + Cycloser-
in + Ethionamide + PAS then;
 6 months:Kanamycin 5 times aweek + previous drugs then;
 12 months: Oﬂoxacin + Cycloserine + Ethionamide +
PAS.
(8) fate of treatment: cure, treatment completed, death,
treatment default, treatment failure or still on treatment.Results
The current study included 200 MDR-TB patients, they were
148 males (74%) and 52 (26%) females. Their ages ranged
from 15 to 76 years (37.83 ± 12.78 years) and males were sig-
niﬁcantly older than females [38.99 ± 12.01 versus
34.52 ± 14.36 years, (P< 0.05)]. Patients lived in rural areas
were 81.5% and those lived in urban areas were 18.5% with
insigniﬁcant difference between males and females regarding
residence. Employed patients were 61.5% and the unemployed
were 38.5%. The percentage of the employed males were sig-
niﬁcantly higher than the employed females (79.4% of males
versus 13.5% of females, P < 0.001) (Table 1). Manual
employment was more prevalent among males than females
(82.2% versus 0%, P< 0.001) while professional employment
was more prevalent among females than males (100% versus
20%, P< 0.001).
42.5% of the studied patients were tobacco smokers with
signiﬁcantly higher prevalence among males [56.8% of males
versus 1.9% of females were tobacco smokers (P< 0.001)],
0.5% of the studied patients were drug addicts, 0.5% of them
were alcoholics and 56.5% had no special habits of medical
importance. Regarding the associated co-morbidities, 15% of
the included patients were diabetics, 4% of them had liver dis-
eases, 1.5% had GIT diseases, 1.5% had heart diseases and
1.5% had other lung diseases. No signiﬁcant difference was
found between males and females according to associated co-
morbidities.
Discussion
Males constituted 74% (148 cases) of patients included in this
retrospective study while females were 26% (52 cases)
(Table 1). This coincides with the epidemiological picture of
tuberculosis where males are more exposed to infection in
the community than females because of occupational and
mental stress or other social factors which prevent females
from seeking medical advice, which may cause false lowering
of the incidence rate in females [3]. The mean age was
37.38 ± 12.78 years, this age represents the period of physical,
mental, and occupational stress. These results coincide with
those found by Kamal [3] who reported that the mean age
was 37.8 ± 11.7 years and males were 69.2% and females were
30.8%; Mohamed [4] who stated that the mean age was
36.7 ± 11.4 years and males were 74.3% and females were
25.7%; Fouad [5] who showed that the mean age was
30.29 ± 11.7 years and the percentage of males was 72.5%
and that of females was 27.5%; and Abdel-Hamid [6] who
Table 1 Demographic data of the studied group.
Age in years Studied group N= 200
Mean (SD)
37.83 (12.78)
Sex N %
Males 148 74
Females 52 26
Occupation N %
Employed 123 (116 males and 7 females) 61.5% (78.4% of males and 13.5% of females)
Unemployed 77 (32 males and 45 females) 38.5% (21.6% of males and 86.5% of females)
Type of employment Males
N= 116
Females
N= 7
X2 P Value
N (%) N (%)
Manual 96 0
82.2
Professional 26.39 <0.001
20 7
17.2 100
Residence N %
Rural 163 81.5
Urban 37 18.5
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were 84% and females were 16%.
Our results showed that males were signiﬁcantly older than
females (38.99 ± 12.01 versus 34.5 ± 14.36 years). In dis-
agreement with our results, Mohamed [4] found insigniﬁcant
difference between males and females according to age. Also,
163 included patients (81.5%) lived in rural areas while those
who lived in urban areas were 37 patients (18.5%). The differ-
ence between males and females according to the residence was
statistically insigniﬁcant. These results were matched with
those found by Fawzy [7] who reported that higher incidence
of MDR-TB was found in patients living in rural areas
(57.2%) compared to those living in urban areas (42.8%).
Regarding the employment, employed patients were 123
cases (61.5%) and the unemployed were 77 cases (38.5%) (Ta-
ble 1), this is probably as employed patients are more liable to
catch infection; 78.4% of males versus 13.5% of females were
employed with a highly signiﬁcant difference. These results
were matched with Mohamed [4] who reported that employed
patients were 76.1% and the unemployed were 23.9% of the
studied patients. 91.6% of males versus 17.3% of females were
employed with a highly signiﬁcant difference.
The employed manual males were 96 patients (82.2%) but
no manual workers were found among females. The employed
professional females were 7 cases (100%) while the employed
professional males were 20 cases (17.2%). The difference be-
tween males and females regarding the type of employment
was highly signiﬁcant. Coinciding with these results, Fawzy
[7] stated that the manual workers had more MDR-TB than
professional workers but no statistically signiﬁcant difference
was found.
The most frequent special habit of the studied patients was
tobacco smoking that represented 42.5% of cases (85 cases).
Drug addiction and alcohol intake represented an equal per-
centage of cases [0.5% of cases (one case) for each]. Tobacco
smoking was more prevalent among males than females with
a highly signiﬁcant difference while no signiﬁcant differenceswere found between males and females regarding alcohol in-
take or drug addiction.
These results were in agreement with Mohamed [4] who sta-
ted that in MDR-TB patients; smokers were 44.2% and non
smokers were 55.8% and tobacco smoking was more prevalent
among males than females with a highly signiﬁcant difference.
Higher percentages of smokers were found by Kamal [3] and
Fawzy [7] who found that among MDR-TB patients; smokers
were 61.53% and 56.4% while non smokers were 38.47% and
43.6%, respectively. No signiﬁcant differences were found be-
tween males and females as regard smoking among the studied
TB patients in both studies.
The most common co-morbidity associated with MDR-TB
patients was diabetes mellitus [15% of the studied patients (30
cases)]. The second co-morbidity was liver disease; represented
by 4% of patients (8 cases). No statistically signiﬁcant differ-
ence could be detected between males and females according
to the associated co-morbidities. In agreement with these re-
sults, Mohamed [4] reported a higher frequency of diabetes
mellitus [15% of the studied patients (17 cases)] than other
co-morbidities in MDR-TB patients with no statistically signif-
icant difference between males and females as regards the asso-
ciated co-morbidities. Also, Kamal [3] found that diabetic
patients constituted 26.9% of the studied patients. A much
higher percentage of diabetes mellitus was found by Fawzy
[7] who reported that 80.7% of the studied MDR-TB patients
were diabetics.
Table 2 shows the history of previous anti-TB treatment
among the studied patients; it revealed that defaulter patients
were 44.5%, treatment failure patients were 44%, relapse pa-
tients were 4%, and new cases constituted 7.5% of the studied
patients. This means that retreated patients were 92.5% and
newly diagnosed patients were 7.5% of the studied group.
Table 2 also shows that patients who received treatment at
hospital were 74 cases (37%), those who received treatment at
home were 111 cases (55.5%) and those who did not receive
any treatment were 15 cases (7.5%). Patients who received
Table 2 The distribution of history of previous anti-TB treatment.
History of previous TB treatment No (%)
Place of treatment Home 111 55.5
Hospital 74 37
No treatment 15 7.5
Regimen of treatment Category 1 13 6.5
Category 2 172 86.5
No treatment 15 7.5
Compliance of treatment Regular 88 44
Irregular 97 48.5
No treatment 15 7.5
Patient type Defaulter 89 44.5
Treatment failure 88 44
Relapse 8 4
New 15 7.5
Table 3 Types of resistance among the studied group.
Type of resistance Studied group N= 200
N (%)
Acquired 185 92.5
Primary 15 7.5
Table 4 Drug sensitivity test results.
Drug sensitivity test Studied group N= 200
N %
HRES resistance 156 78
HRS resistance 41 20.5
HRE Resistance 3 1.5
Resistance to Isoniazid 200 100%
Resistance to Rifampicin 200 100%
Resistance to Streptomycin 197 98.5%
Resistance to Ethambutol 159 79.5%
Table 5 Distribution of sputum conversion per month.
Sputum conversion N %
2 1 0.5
3 48 24
4 69 34.5
5 15 7.5
6 20 10
7 2 1
9 4 2
No 41 20.5
Mean ± SD 4.19 ± 1.28 months
Range 2–9 months
Table 6 Treatment outcome of MDR-TB among the studied
group.
Treatment outcome Studied group N= 200
N %
Favorable outcome 132 66
Treatment failure 19 9.5
Defaulter 28 14
Died 21 10.5
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ceived category 2 treatment were 172 cases (86%), and those
who did not receive any anti-TB treatment were 15 cases
(7.5%). According to the compliance, the table shows that
there were 97 cases (48.5%) with irregular drug intake and
88 cases (44%) with regular drug intake.
Lower percentages of defaulters, relapse patients and new
cases and a higher percentage of treatment failure patients
were found by Mohamed [4] who reported that defaulter pa-
tients were 33.6%, relapse patients were 0.9%, new cases were
4.4% and treatment failure patients were 61.1% of the studied
patients. The mean retreated patients were 95.6% and the new-
ly diagnosed patients were 4.4% of the studied patients.
Also, Mohamed [4] found that the patients received cate-
gory1 treatment were 7.1%, those who received category 2
treatment were 88.5%, and those who did not receive any
treatment were 4.4% of the studied patients. There were
54.7% of patients with irregular drug intake and 40.9% with
regular drug intake. Patients who received treatment at hospi-
tal were 79%, those who received treatment at home were
16.6%, and those who did not receive treatment were 4.4%.
A higher percentage of new cases was found by Kamal [3]
who reported that 46.2% of the studied MDR-TB patients
were new cases while the defaulters were 19.2% and the relapse
cases were 34.6% of the studied patients.
In Table 3, acquired resistance was 92.5% and primary
resistance was 7.5%. This might be due to lack of patients’
adherence to chemotherapy or inappropriate regimens of treat-
ment. These results coincided with those reported by Abdel-
Hamid [6] who found that the acquired MDR-TB cases were
higher than the primary MDR-TB cases (72% versus 28%).
Table 4 shows that the percentages of resistance to Isonia-
zid, Rifampicin, Streptomycin and Ethambutol were 100%,
100%, 98.5% and 79.5%, respectively. In agreement withour results, Kamal [3] reported that the percentages of resis-
tance to Isoniazid, Rifampicin, Streptomycin and Ethambutol
were 100%, 100%, 80.8% and 38.5%, respectively. Also,
Table 7 The relation between treatment outcome and the type of patients.
Type of patient Favorable outcome N= 132 Unfavorable outcome N= 68 X2 P Value
N % N %
Defaulter 46 34.8 42 61.8 13.2 <0.001
Treatment failure 69 52.3 20 29.4 9.5 <0.001
Relapse 5 3.8 3 4.4 0.05 >0.05
New 12 9.1 3 4.4 1.42 >0.05
Table 8 Frequency of drug complications.
Complications Studied Group N= 200
N %
Hypothyroidism 79 39.5
Depression 53 26.5
Peripheral neuropathy 132 66
GIT 177 88.5
Others 105 52.5
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azid, Rifampicin, Streptomycin and Ethambutol were 100%,
100%, 91.1% and 79.6% respectively. Lower results were
reported by Fawzy [7] who found that the percentages of resis-
tance to Isoniazid, Rifampicin, Streptomycin and Ethambutol
were 54.5%, 52.2%, 40% and 28.4% respectively. These low
percentages of resistance found by Fawzy [7] may be explained
by the low percentage of MDR-TB patients included in this
study [21 MDR-TB patients out of 128 studied TB patients
(16.4%)] and this may give low presentative data.
Table 5 shows that the duration for sputum conversion
ranged from 2 to 9 months (4.19 ± 1.28 months). In
agreement with these results, Mohamed [4] reported that the
duration of sputum conversion was 5.5 ± 1.2 months. In Ta-
ble 6; the fate of MDR-TB treatment was favorable outcome
in 132 cases (66%), 28 patients were defaulters (14%), 21 pa-
tients died (10.5%) and 19 patients had treatment failure
(9.5%). No signiﬁcant difference could be detected between
males and females according to the fate of treatment. In agree-
ment with these results Masjedi et al. [8] reported that 67.5%
of patients had successful outcome and 32.5% had poor out-
come (treatment failure 14% and 18.5% died). Also, Helen
et al. [9] reported that 62% of patients had successful treat-
ment, 15% died, 14% were defaulters, and 8% of them had
treatment failure. Worse outcome was noticed in the study
done by Munsiff et al. [10] who reported that patients had suc-
cessful outcome in 40% of cases, defaulters were 13% and
47% of patients were died.
In Table 7; the prevalence of defaulter patients was signiﬁ-
cantly higher among unfavorable outcome patients while the
prevalence of treatment failure patients was signiﬁcantly high-
er among favorable outcome.
Table 8 shows that the most common complications were
GIT manifestations in 88.5%, peripheral polyneuritis in
66%, hypothyroidism in 39.5%, depression in 26.5% and
other complications as electrolytes disturbance, skin
manifestations, arthralagia, and psychosis in 52.5% of pa-
tients. There was insigniﬁcant difference between males and fe-
males according to the frequency of drug complications.
Coinciding with our results, Mohamed [4] reported that the
most frequent complications of anti-TB drugs were gastroin-testinal manifestations in 84% then polyneuropathy in
57.5% of the studied patients. Also, Dhingra et al. [11] re-
ported that in India the most frequent organs affected by anti
TB drugs were the gastrointestinal tract in 53% of patients and
the commonest presenting complaints were nausea and vomit-
ing. Lastly, Kishore et al. [12] who reported that the adverse
effects of anti-TB treatment were hepatobiliary in 57.1%, gas-
trointestinal in 14.3%, skeletal in 9.5%, cutaneous in 7.1%, re-
nal in 4.8%, neurological in and ocular in 2.4%.Conclusion
More than two thirds of Egyptian MDR-TB patients could be
effectively treated and cured in Abbassia Chest Hospital.References
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